Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cibus, Inc.CLXT · Entity 6658 | Chief Executive Officer | December 31, 2020 | January 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cibus, Inc.
Report date December 31, 2020 · Filed January 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 186,282 |
Reported balance
After 2020-12-31 transaction · row 1
1 source rowRow 1 · 2020-12-31 · Sale · Disposed 4,140 · Balance 186,282 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 26, 2020. F2: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $4.13 to $4.32, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 26, 2020.
F2: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $4.13 to $4.32, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2020 Filed Jan 4, 2021 22:12 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 4,140 | $4.17 | $17,280.77 |
DisclosureSEC source: 0001615594-21-000001 · primary_doc.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,282 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 26, 2020. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $4.13 to $4.32, inclusive. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 21:09 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 4,140 | $5.59 | $23,123.56 |
DisclosureSEC source: 0001615594-20-000067 · primary_doc.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,422 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 26, 2020. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $5.45 to $5.74, inclusive. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 22:46 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 175,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000055 · primary_doc.xml · derivative · entry 2 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| July 01, 2020 Filed Jul 31, 2020 21:12 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 3,495 | $4.65 | $16,268.18 |
DisclosureSEC source: 0001615594-20-000045 · primary_doc.xml · nonDerivative · entry 2 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,562 F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $4.55 to $4.9458, inclusive. Read SEC document |
| June 29, 2020 Filed Jul 31, 2020 21:12 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 2,902 | $5.01 | $14,531.77 |
DisclosureSEC source: 0001615594-20-000045 · primary_doc.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,057 F1 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $4.955 to $5.03, inclusive. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:21 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 3,177 | $2.96 | $9,388.99 |
DisclosureSEC source: 0001615594-20-000020 · primary_doc.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,959 Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 16:36 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantPerformance Stock Units · Derivative | 166,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-19-000024 · primary_doc.xml · derivative · entry 3 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,667 Underlying: Common Stock · 166,667 shares Expires 2022-06-28 F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one share of Calyxt common stock. The PSU will vest as to 50%, 100% or 120% of the shares at the end of a three year performance period based upon increases in Calyxt common stock from the starting price of $12.48 (and on a linear basis between vesting percentages) and if vested, will be issued as restricted stock with restrictions lapsing on the two year anniversary of the date of issuance. F3 · derivative.exercise_date: Each performance stock unit (PSU) represents a contingent right to receive one share of Calyxt common stock. The PSU will vest as to 50%, 100% or 120% of the shares at the end of a three year performance period based upon increases in Calyxt common stock from the starting price of $12.48 (and on a linear basis between vesting percentages) and if vested, will be issued as restricted stock with restrictions lapsing on the two year anniversary of the date of issuance. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 16:36 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 125,000 | $0.00 Strike: $12.48 | $0.00 |
DisclosureSEC source: 0001615594-19-000024 · primary_doc.xml · derivative · entry 2 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2029-06-28 F2 · derivative.exercise_date: Stock Option vests as to 15% of the underlying shares on the first anniversary of the Grant Date, as to 10% of the underlying shares on the second anniversary of the Grant Date, and as to 5% of the underlying shares on the last day of each calendar quarter beginning the first full calendar quarter after the second anniversary of the Grant Date. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 16:36 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-19-000024 · primary_doc.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,136 F1 · shares: 50,000 Restricted Stock Units with respect to Calyxt, Inc. common stock were granted to reporting person on 6/28/2019 and vest as to 15% of the underlying shares on the first anniversary of the Grant Date, as to 10% of the underlying shares on the second anniversary of the Grant Date, and as to 5% of the underlying shares on the last day of each calendar quarter beginning on the first full calendar quarter after the second anniversary of the Grant Date. Read SEC document |
| April 02, 2019 Filed Apr 4, 2019 20:07 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 2,582 | $16.65 | $42,982.04 |
DisclosureSEC source: 0001127602-19-014799 · form4.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,136 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.56 to $16.85, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 135,000 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on September 17, 2018 and remain unvested; 27,000 shares will vest on the October 1, 2019, and the remainder vesting quarterly (commencing with the fourth fiscal quarter of 2019) in equal installments over 36 months. Read SEC document |
| March 26, 2019 Filed Mar 27, 2019 20:22 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleRestricted Stock Units | 2,582 | $17.87 | $46,128.98 |
DisclosureSEC source: 0001127602-19-013430 · form4.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,718 F1 · security: The award of restricted stock units with respect to Calyxt, Inc. common stock was granted on September 17, 2018 and vested 25% on October 1, 2018, with 15% vesting on October 1, 2019, and the remainder vesting quarterly (commencing with the fourth fiscal quarter of 2019) in equal installments over 36 months. F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.64 to $18.09, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 01:26 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleRestricted Stock Units | 2,582 | $17.32 | $44,713.01 |
DisclosureSEC source: 0001127602-19-012485 · form4.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,300 F1 · security: The award of restricted stock units with respect to Calyxt, Inc. common stock was granted on September 17, 2018 and vested 25% on October 1, 2018, with 15% vesting on October 1, 2019, and the remainder vesting quarterly (commencing with the fourth fiscal quarter of 2019) in equal installments over 36 months. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.02 to $17.63, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| March 12, 2019 Filed Mar 15, 2019 20:03 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleRestricted Stock Units | 2,582 | $16.58 | $42,802.33 |
DisclosureSEC source: 0001127602-19-011547 · form4.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,882 F1 · security: The award of restricted stock units with respect to Calyxt, Inc. common stock was granted on September 17, 2018 and vested 25% on October 1, 2018, with 15% vesting on October 1, 2019, and the remainder vesting quarterly (commencing with the fourth fiscal quarter of 2019) in equal installments over 36 months. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $17.26, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| October 08, 2018 Filed Oct 10, 2018 21:20 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $14.24 | $0.00 |
DisclosureSEC source: 0001127602-18-029912 · form4.xml · derivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2028-10-08 F1 · derivative.exercise_date: The Stock Option was granted on October 8, 2018 and vests 15% on October 8, 2019 and 15% on October 8, 2020, with the remainder vesting quarterly (commencing with the first fiscal quarter of 2021) in equal installments over 42 months. Read SEC document |
| October 01, 2018 Filed Feb 14, 2019 21:56 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingRestricted Stock Units | 15,536 | $14.83 | $230,398.88 |
DisclosureSEC source: 0001127602-19-006028 · form5.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,464 F1 · security: The award of restricted stock units with respect to Calyxt, Inc. common stock was granted on September 17, 2018 and vested 25% on October 1, 2018, with 15% vesting on October 1, 2019, and the remainder vesting quarterly (commencing with the fourth fiscal quarter of 2019) in equal installments over 36 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.